Martell Christopher - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, Martell Christopher's relationship to Candel Therapeutics, Inc. (CADL) is Director, and currently has 111,349 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CADL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Martell Christopher - Insider Non-Derivative Transactions of CADL Common Stock

Martell Christopher - Insider Non-Derivative Transactions at CADL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Acquisition -- (Common Stock)	111349	4.67	111349
Dec 10, 2022	P -- (Common Stock)	23950	1.92	152000
Dec 9, 2022	P -- (Common Stock)	3050	1.68	128050